At the time of writing, Idexx Laboratories, Inc [IDXX] stock is trading at $422.62, up 1.09%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The IDXX shares have gain 1.71% over the last week, with a monthly amount drifted -4.97%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Idexx Laboratories, Inc [NASDAQ: IDXX] stock has seen the most recent analyst activity on December 02, 2024, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $500. Previously, BTIG Research started tracking the stock with Buy rating on July 25, 2024, and set its price target to $580. On January 30, 2024, downgrade downgraded it’s rating to Neutral but maintained its price target of $525 on the stock. Exane BNP Paribas started tracking the stock assigning a Outperform rating and suggested a price target of $602 on December 07, 2023. Cleveland Research upgraded its rating to a Buy. Atlantic Equities downgraded its rating to Neutral for this stock on August 02, 2023, but kept the price target unchanged to $610. In a note dated July 25, 2022, Stifel downgraded an Hold rating on this stock but restated the target price of $415.
For the past year, the stock price of Idexx Laboratories, Inc fluctuated between $398.50 and $583.39. Currently, Wall Street analysts expect the stock to reach $479.75 within the next 12 months. Idexx Laboratories, Inc [NASDAQ: IDXX] shares were valued at $422.62 at the most recent close of the market. An investor can expect a potential return of 13.52% based on the average IDXX price forecast.
Analyzing the IDXX fundamentals
According to Idexx Laboratories, Inc [NASDAQ:IDXX], the company’s sales were 3.84B for trailing twelve months, which represents an 6.56% jump. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.23%. To continue investigating profitability, this company’s Return on Assets is posted at 0.26, Equity is 0.55 and Total Capital is 0.48. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.54.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 415.53 points at the first support level, and at 408.43 for the second support level. However, for the 1st resistance point, the stock is sitting at 426.87, and for the 2nd resistance point, it is at 431.11.
Ratios To Look Out For
It is important to note that Idexx Laboratories, Inc [NASDAQ:IDXX] has a current ratio of 1.36. As well, the Quick Ratio is 0.98, while the Cash Ratio is 0.31. Considering the valuation of this stock, the price to sales ratio is 9.00, the price to book ratio is 21.43 and price to earnings (TTM) ratio is 40.77.
Transactions by insiders
Recent insider trading involved Vandebroek Sophie V., Director, that happened on Nov 27 ’24 when 344.0 shares were sold. Director, Vandebroek Sophie V. completed a deal on Nov 27 ’24 to buy 344.0 shares. Meanwhile, Director SZOSTAK M ANNE sold 500.0 shares on Sep 06 ’24.
